BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2185109)

  • 41. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.
    DeFronzo RA; Ferrannini E; Simonson DC
    Metabolism; 1989 Apr; 38(4):387-95. PubMed ID: 2657323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced glucose-induced thermogenesis is present in noninsulin-dependent diabetes mellitus without obesity.
    Gumbiner B; Thorburn AW; Henry RR
    J Clin Endocrinol Metab; 1991 Apr; 72(4):801-7. PubMed ID: 2005204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration.
    Katz H; Homan M; Jensen M; Caumo A; Cobelli C; Rizza R
    Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal model analyses of beta cell secretion, insulin sensitivity and glucose effectiveness in glucose tolerant, non-diabetic first-degree relatives of Ghanaian patients with type 2 diabetes and healthy control subjects.
    Amoah AG; Owusu SK; Ayittey OM; Schuster DP; Osei K
    Ethn Dis; 2001; 11(2):201-10. PubMed ID: 11455994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus.
    Ludvik B; Nolan JJ; Roberts A; Baloga J; Joyce M; Bell JM; Olefsky JM
    J Clin Invest; 1997 Nov; 100(9):2354-61. PubMed ID: 9410915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How insulin resistant are patients with noninsulin-dependent diabetes mellitus?
    Reaven GM; Chen YD; Donner CC; Fraze E; Hollenbeck CB
    J Clin Endocrinol Metab; 1985 Jul; 61(1):32-6. PubMed ID: 3889039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyper insulinism and decreased insulin sensitivity in nonobese healthy offspring of conjugal diabetic parents and individuals with IGT and NIDDM.
    Rao CA; Snehalatha C
    Indian J Physiol Pharmacol; 1996 Apr; 40(2):139-44. PubMed ID: 9062808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
    Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
    J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
    Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS; Elliott T
    Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperinsulinemia in offspring of non-insulin-dependent diabetes mellitus patients: the role played by abnormal clearance of insulin.
    Cozzolino D; Sessa G; Salvatore T; Sasso FC; Giugliano D; Torella R
    Metabolism; 1995 Oct; 44(10):1278-82. PubMed ID: 7476284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic abnormalities in first-degree relatives of type 2 diabetics.
    Di Pietro S; Suraci C
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):631-8. PubMed ID: 2083058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for an abnormality specific to glucose metabolism.
    Wells AM; Sutcliffe IC; Johnson AB; Taylor R
    Diabetes; 1993 Apr; 42(4):583-9. PubMed ID: 8384133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated in vivo insulin clearance in pima indians with non-insulin-dependent diabetes mellitus.
    Vasquez B; Reaven GM; Andrews WJ
    Diabetes; 1985 Jul; 34(7):671-6. PubMed ID: 3891474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
    Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
    Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.